GC Biopharma's Hunter Syndrome treatment 'Hunterase' receives drug approval in India and Taiwan

GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...

August 24, 2026 | Monday | News
Korea's Hanmi Pharm signs $2.3 B deal with Genentech for novel obesity therapy

South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...

August 25, 2026 | Tuesday | News
China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...

August 24, 2026 | Monday | Influencers
Global CRO Novotech strengthens presence in Japan with new Tokyo office

Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...

August 24, 2026 | Monday | News
Taiwan's Lotus Pharma inks biosimilars agreement with Alvotech for US and selected Asian markets

Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...

August 25, 2026 | Tuesday | News
Korea's Rznomics joins Lilly Gateway Labs in US to accelerate RNA Therapeutics

South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies,...

August 24, 2026 | Monday | News
Genentech injects $750 M in new device fill-finish manufacturing facility in US

Genentech, a member of the Roche Group, has announced plans to invest approximately $750 million in a new device fill-fi...

August 21, 2026 | Friday | News
Charles River Laboratories collaborates with Taiwan's Medigen Vaccine Biologics Corp

US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...

August 24, 2026 | Monday | News
Taiwan's Astron Medtech receives Presidential Award, accelerates US commercial expansion

Aztron Medtech Corporation, a US-based orthopaedic device company, has announced that its Taiwan subsidiary, Astron Medt...

August 21, 2026 | Friday | News
Australia's OncoSil Medical secures US FDA approval for cancer radiation device

Australia-based OncoSil Medical, a medical device company developing targeted radiation therapies for difficult-to-treat...

August 21, 2026 | Friday | News
Ono Pharma's Opdivo intravenous infusion wins additional approval in Taiwan

Japan-based Ono Pharmaceutical has announced that Ono Pharma Taiwan, a Taiwanese subsidiary of Ono, has received the add...

August 20, 2026 | Thursday | News
Japan's Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351

Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GS...

August 20, 2026 | Thursday | News
Mankind Pharma inks diabetes deal with Chongqing Chenan Biopharma

Mankind Pharma, one of India’s leading pharmaceutical companies, has entered into an exclusive in-licensing and ma...

August 20, 2026 | Thursday | News
Next-Gen Cell Therapy Starts with the Right T Cells

  As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...

August 19, 2026 | Wednesday | Influencers
Korean medtech player Rayence launches portable X-ray diagnostic solutions

Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced the launch o...

August 20, 2026 | Thursday | News
Chinese startup Enginprime Medical closes $12 M Series A financing

Enginprime Medical, a developer of percutaneous ventricular assist device (pVAD) technology, has announced the closing o...

August 18, 2026 | Tuesday | News
LEO Pharma buys Tanabe’s rare disease drug dersimelagon for $435 M

LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an...

August 18, 2026 | Tuesday | News
Lonza launches rapid custom media prototyping service for early bioprocess development

Switzerland-based Lonza, the world's leading contract development and manufacturing organization (CDMO), has announced i...

August 18, 2026 | Tuesday | News
Chinese startup Norroy Bioscience receives US FDA approvals for kidney cancer imaging product

Norroy Bioscience, a China-based clinical-stage biotechnology startup focused on innovative targeted radiopharmaceutical...

August 19, 2026 | Wednesday | News
Singapore approves GSK's Blenrep combinations for treatment of relapsed/refractory multiple myeloma

GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved Blenrep for the treatment of...

August 19, 2026 | Wednesday | News
Henlius and Sandoz enter strategic collaboration worth $322 M to unlock global value of biosimilars platform

Shanghai Henlius Biotech has entered into a strategic collaboration with Sandoz, a global leader in generics and bi...

August 17, 2026 | Monday | News
Intuitive expands medtech manufacturing footprint in Asia Pacific with new facility in Malaysia

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), ...

August 17, 2026 | Monday | News
Abu Dhabi forges strategic partnership with US to accelerate drug discovery and translational research

As healthcare systems worldwide seek faster and more effective ways to turn scientific breakthroughs into improved patie...

August 17, 2026 | Monday | News
Can AI Prevent the Next GMP Cold Storage Failure?

In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...

August 17, 2026 | Monday | Opinion
Australia’s Next Cell & Gene Therapy Leap: From Clinical Trials to Commercial Scale

Australia is rapidly evolving beyond its reputation as a destination for early-stage clinical trials to build a more com...

August 17, 2026 | Monday | Influencers